Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem, Neville E. Sanjana, Ella Hartenian et al. · Science · 2013
The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a new way to interrogate gene function on a genome-wide scale. We show that lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO) library targeting 18,080 genes with 64,751 unique guide sequences enables both negative and positive selection screening in human cells. First, we used the GeCKO library to identify genes essential for cell viability in cancer and pluripotent stem cells. Next, in a melanoma model, we screened for genes whose loss is involved in resistance to vemurafenib, a therapeutic RAF inhibitor. Our highest-ranking candidates include previously validated genes NF1 and MED12, as well as novel hits NF2, CUL3, TADA2B, and TADA1. We observe a high level of consistency between independent guide RNAs targeting the same gene and a high rate of hit confirmation, demonstrating the promise of genome-scale screening with Cas9.
Cited by 5,210 works. doi:10.1126/science.1247005 Open-access PDF
Authors
- Ophir Shalem
- Neville E. Sanjana
- Ella Hartenian
- Xi Shi
- David A. Scott
- Tarjei S. Mikkelsen
- Dirk Heckl
- Benjamin L. Ebert
- David E. Root
- John G. Doench
- Feng Zhang
References
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
- Mutations of the BRAF gene in human cancer
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- RNA-Guided Human Genome Engineering via Cas9
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- DNA targeting specificity of RNA-guided Cas9 nucleases
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering